Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,068 | 249 | 96.5% |
| Education | $111.00 | 3 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $547.61 | 51 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $459.63 | 38 | $0 (2021) |
| Astellas Pharma US Inc | $330.45 | 17 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $260.65 | 19 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $239.51 | 18 | $0 (2021) |
| Novo Nordisk Inc | $221.60 | 16 | $0 (2021) |
| PFIZER INC. | $152.41 | 11 | $0 (2021) |
| Amgen Inc. | $133.59 | 8 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $114.57 | 8 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $94.03 | 16 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $514.65 | 38 | Lilly USA, LLC ($145.33) |
| 2020 | $463.67 | 37 | Lilly USA, LLC ($111.61) |
| 2019 | $833.04 | 63 | Astellas Pharma US Inc ($217.26) |
| 2018 | $751.41 | 62 | Janssen Pharmaceuticals, Inc ($137.60) |
| 2017 | $616.61 | 52 | Janssen Pharmaceuticals, Inc ($172.88) |
All Payment Transactions
252 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: DIABETES | ||||||
| 11/15/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, SYNJARDY | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: DIABETES | ||||||
| 11/09/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Diabetes | ||||||
| 09/13/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Diabetes | ||||||
| 08/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/16/2021 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: CNS | ||||||
| 08/09/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Cardiovascular | ||||||
| 08/03/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: DIABETES | ||||||
| 08/02/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.18 | General |
| Category: Cardiovascular | ||||||
| 07/27/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Neuroscience | ||||||
| 07/13/2021 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: VACCINES | ||||||
| 06/23/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Diabetes | ||||||
| 06/15/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Diabetes | ||||||
| 06/14/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: PRIMARY CARE | ||||||
| 06/07/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: Cardiovascular | ||||||
| 05/25/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/24/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: Neuroscience | ||||||
| 05/11/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Respiratory | ||||||
| 04/29/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Gastroenterology | ||||||
| 04/27/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/20/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Diabetes | ||||||
| 04/19/2021 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: Neuroscience | ||||||
| 03/30/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 342 | 651 | $173,422 | $29,548 |
| 2020 | 6 | 374 | 834 | $188,356 | $28,863 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 186 | 402 | $109,788 | $15,585 | 14.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2021 | 49 | 49 | $19,404 | $6,248 | 32.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 22 | 112 | $23,184 | $4,693 | 20.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 42 | 45 | $17,520 | $2,633 | 15.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 17 | 17 | $2,856 | $279.64 | 9.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 26 | 26 | $670.00 | $109.48 | 16.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 217 | 592 | $133,703 | $18,236 | 13.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 2020 | 42 | 42 | $14,547 | $4,741 | 32.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 39 | 51 | $16,728 | $2,842 | 17.0% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 25 | 91 | $19,081 | $2,564 | 13.4% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Facility | 2020 | 25 | 25 | $3,425 | $300.15 | 8.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 26 | 33 | $872.00 | $180.57 | 20.7% |
About Dr. Robert Dohlman, MD
Dr. Robert Dohlman, MD is a Emergency Medicine healthcare provider based in Durand, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154381069.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Dohlman, MD has received a total of $3,179 in payments from pharmaceutical and medical device companies, with $514.65 received in 2021. These payments were reported across 252 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,068).
As a Medicare-enrolled provider, Dohlman has provided services to 716 Medicare beneficiaries, totaling 1,485 services with total Medicare billing of $58,411. Data is available for 2 years (2020–2021), covering 12 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Durand, WI
- Active Since 03/24/2006
- Last Updated 01/10/2020
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1154381069
Products in Payments
- XARELTO (Drug) $268.28
- MYRBETRIQ (Drug) $234.37
- TRULICITY (Drug) $208.44
- INVOKANA (Drug) $185.33
- Ozempic (Drug) $139.73
- TRADJENTA (Drug) $136.02
- FARXIGA (Drug) $118.01
- ENTRESTO (Drug) $114.57
- XIFAXAN (Drug) $112.64
- STIOLTO RESPIMAT (Drug) $108.20
- EMGALITY (Drug) $102.79
- HUMALOG (Drug) $89.41
- Aimovig (Biological) $75.03
- JARDIANCE (Drug) $67.19
- GLYXAMBI (Drug) $56.32
- CHANTIX (Drug) $51.04
- ADVAIR (Drug) $50.16
- Dexilant (Drug) $45.98
- Victoza (Drug) $42.58
- BYDUREON (Drug) $39.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.